Search Results for "psa screening"
STAT provides readers with necessary details to make sense of new PSA screening study
A thorough, nuanced and balanced examination of a re-analysis of two major PSA trials show the complexities involved in PSA screening research and underscores the difficulty physicians and patients face when it comes prostate cancer prevention.
A new study claims prostate cancer screenings significantly reduce deaths. Not everyone agrees
LA Times portrays PSA screening analysis as far more clear-cut and definite than even the authors claim
The headline and lead paragraphs include statements about screening saving lives, without telling readers about key limitations and uncertainties in the new analysis.
PSA screening for prostate cancer saves lives after all, study says
Abandoning PSA Screening Could Cost Lives: Study
We’re told that researchers constructed a model – but there is no critical evaluation of that model.
Abandoning PSA Screening Could Cost Lives: Study
Thoughtful week-after analysis of PSA screening recommendations
Too often, the demands of same-day journalism dictate that today’s announcement is reported and then journalists move on to the next day’s announcement and the next day’s journal study without a chance to step back and reflect. Appropriately, some journalists are taking/finding the time to reflect on last week’s prostate cancer screening recommendations from the […]4 1/6/2012
“No evidence of mortality benefit for annual PSA screening”
A paper published today in the Journal of the National Cancer Institute brings new focus to the questions already raised about prostate cancer screening. Headlines: Prostate Cancer Screening Shows No Benefit – New York Times “Updated findings from one of the largest studies of prostate cancer screening show that the commonly used P.S.A. blood test […]2 3/29/2011
"Excessive PSA screening in elderly men with limited life expectancies remains a significant problem"
A study in the Journal of Clinical Oncology found that “that men in their seventies had prostate cancer screening nearly twice as often as men in their early fifties, who are more likely to benefit from prostate cancer detection and treatment.” An American Society for Clinical Oncology news release includes this quote: “Our findings show […]6/21/2010
NY Daily News begins second decade of evading evidence on PSA screening
Headlines every day in the New York Daily News are luring men in as part of a mass prostate cancer screening campaign which the American Cancer Society not only does not endorse – its chief medical officer recommends against. Yet the paper brags that it is beginning its second decade of this non-evidence-based campaign. Sample […]12
Is PSA now “OK”? What the task force really said about the evidence on prostate cancer screening
Reading the headlines on the US Preventive Services Task Force’s (USPSTF) update to its prostate cancer screening guidelines, you might come away with the idea that the task force has completely reversed its 2012 recommendation against broad-based prostate-specific antigen (PSA) screening. But that would be the wrong impression. What the revised guideline does is make a […]4/9/2013
3 items in this week’s news with caveats about various screenings: pap, PSA, oral
Pap smears Under the headline, “Doctors Too Pap-Happy,” HealthDay reports: “Most primary care physicians advise women to get “Pap” tests for cervical cancer screening more often than clinical guidelines recommend, new research reveals.” PSA tests Reuters Health explained: “The American College of Physicians (ACP) became the latest group to ask doctors to be clear about […]3
A prostate ‘Pep Talk’ is the wrong way to get men thinking about cancer screening
With September’s Prostate Cancer Awareness Month in full swing, an industry-affiliated partnership has turned to high-profile former NFL coaches to deliver its prostate cancer screening message. It’s a clever choice: professional coaches are good at getting men to do all kinds of things they might not otherwise want to do, whether it’s extra wind sprints […]9
Most news coverage on new PSA testing study acknowledged costly trade-offs
The major health news story last week was on a re-assessment of prostate cancer screening published in the Annals of Internal Medicine. The study’s release generated stories in the New York Times, TIME, Consumer Reports, STAT, ABS-CBN News (Philippines) and the LA Times, among others. The reporting confirms what we already know about the PSA test […]
Imbalanced ‘Saved by the Scan’ campaign neglects big concerns over lung cancer screening
Everyone who has ever smoked cigarettes should take this quiz because “Lung cancer screening could save your life,” according to the American Lung Association’s (ALA) new “Saved by the Scan” campaign. But after taking that quiz, almost all current or former smokers (roughly 9 out of 10) will learn that they’re not good candidates for […]
Even casual readers expect more than broad claims about screening tests. Where’s the data?
A new blood test “substantially reduces” the need for biopsy, but by how much really? Benefit data are given only in relative terms in this news release.
Study: New blood test is more accurate in predicting prostate cancer risk than PSA
WHO exposes deceptive promotion of industry-supported FRAX osteoporosis screening tool
When the World Health Organization (WHO) speaks people usually listen. As the planet’s premier health policy-making body, the WHO influences healthcare and medical practice around the globe. Their expert committees create reports that underpin guidelines, affecting the health care delivered by practitioners on every continent. When the WHO issues a particularly controversial statement, you’d think […]1
Prostate Week continues: Yale Cancer Center also flouting evidence with public prostate screening event
It’s been a big week for prostate screening news and we’re not finished yet. We fact-checked Donald Trump’s health sit-down with Dr. Oz and explored the misleading messages it produced about prostate-specific antigen (PSA) testing. We looked at coverage of a new clinical trial showing that active monitoring in screen-detected early prostate cancer produces outcomes […]